Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Clinical trial NCT05492123 · RECRUITING

Trial details

NCT number: NCT05492123
Sponsor: Hospital Israelita Albert Einstein
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Cervical Neoplasms

Start date: 2022-08-30
Primary completion: 2026-12-31
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.